Five Texas infusion centers have exhausted their supply of the only monoclonal antibody therapy used to treat the omicron variant, The Dallas Morning News is reporting.
Centers in Austin, El Paso, Fort Worth, San Antonio, and The Woodlands are not expecting to be able to offer the treatment again until sometime in January when another shipment of the drug sotrovimab is expected from the federal government, the newspaper said.
“We have been shifting supply around, but there’s so little left at this point that it’s not going to buy significant additional time,” Chris Van Deusen, a spokesperson for the Texas Department of State Health Services, said in a statement.